Company intelligence / Profile preview

Curate Therapeutics

Los Angeles area or Southern California*, California, United Statescuratetherapeutics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has developed the Curate Cell Processing System, an automated platform that delivers a greater number of T cells at higher purity for use in cell therapies. The system has been validated with both academic and commercial partners, demonstrating superior extraction of high-purity T-cells compared to other platforms. The company is preparing for commercial launch and has received significant funding and NIH grants to support this effort[3].

Therapeutic areas: Oncology
Modalities: Cell therapy (enabling technology for cell processing, especially T cells)
Industry: Therapeutic Medical Devices

Partnerships

City of Hope (academic/commercial evaluation partner)[3]

Beyond the preview

Go deeper on Curate Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curate Therapeutics.

Explore the full profile